home / stock / vyyrf / vyyrf news

VYYRF News and Press, Voyageur Minerals Ltd From 08/12/21

Stock Information
Company Name: Voyageur Minerals Ltd
Stock Symbol: VYYRF
Market: OTC
Website: voyageurpharmaceuticals.ca
Menu
VYYRF VYYRF Quote VYYRF Short VYYRF News VYYRF Articles VYYRF Message Board
Get VYYRF Alerts

News, Short Squeeze, Breakout and More Instantly...
VYYRF - Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options and Deferred Share Units

(TheNewswire) Calgary, Alberta – TheNewswire - August 12, 2021 – Voyageur Pharmaceuticals Ltd. ( TSXV : VM ) USA (OTC : VYYRF) (the "Company" or "Voyageur") announced that it has issued 200,000 optio...
VYYRF - Voyageur Pharmaceuticals Announces Board of Director Changes and 2nd quarter Financial Results

(TheNewswire) Calgary, Alberta - TheNewswire - July 26 th , 2021 - Voyageur Pharmaceuticals Ltd . (TSXV : VM) (OTC:VYYRF) (the “Company” or “Voyageur”). Voyageur is very pleased to announce that Frank Wright a...

VYYRF - Voyageur Pharmaceuticals Ltd. Announces Completion of Private Placement

(TheNewswire) Calgary, Alberta - TheNewswire - June 14, 2021 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM) ( OTC:VYYRF ) (the "Company" or "Voyageur") announces that, further to news releases dated April 13 and 23, and May 5 and 28, 2021, Voyageur ...

VYYRF - Voyageur Pharmaceuticals Ltd. Announces Closing of Second Tranche of Private Placement

(TheNewswire) Calgary, Alberta – TheNewswire - May 28, 2021 – Voyageur Pharmaceuticals Ltd. ( TSX.V:VM) ( OTC:VYYRF ) (the "Company" or "Voyageur") announces that, further to news releases dated April 13 and 23, 2021 and May 5, 202...
VYYRF - Voyageur Pharmaceuticals Ltd. Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast

Calgary, Alberta, May 18, 2021 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. ( TSX.V:VM) ( OTC:VYYRF ) (the "Company" or "Voyageur") is pleased to announce that it has received approval from Health Canada (HC) for its fifth product, MultiXthick barium sulfate suspension ...

VYYRF - Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast

(TheNewswire) Calgary, Alberta - TheNewswire - May 17, 2021 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM) ( OTC:VYYRF ) (the "Company" or "Voyageur") is pleased to announce that it has received approval from Health Canada (HC) for its fifth product...

VYYRF - Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product Licenses for MultiXThin Radiographic Barium Contrast

(TheNewswire) Calgary, Alberta - TheNewswire - May 5, 2021 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM) ( OTC:VYYRF ) (the "Company" or "Voyageur") is pleased to announce that it has received approval from Health Canada (HC) for its product, M...
VYYRF - Voyageur Pharmaceuticals Ltd. Issued 4th Health Canada License For Radiographic Barium Contrast Product

Calgary, Alberta, May 04, 2021 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. ( TSX.V:VM) ( OTC:VYYRF ) (the "Company" or "Voyageur") is pleased to announce that it has received approval from Health Canada (HC) for its product, MultiXthin barium sulfate suspension . Multi...

VYYRF - Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement

(TheNewswire) Calgary, Alberta - TheNewswire - April 23, 2021 - Voyageur Pharmaceuticals Ltd. ( TSXV : VM ) ( OTC : VYYRF) (the "Company" or "Voyageur") is pleased to announce that it has increased the pre...

VYYRF - InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals and Beneficial Ruling by the D.C. Circuit Court of Appeals Qualifying Voyageurs Products as Devices not Drugs - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - April 21, 2021) - Voyageur Pharmaceuticals (TSXV: VM) (OTC Pink: VYYRF) announced that the D.C. Circuit Court of Appeals has upheld a prior ruling that concluded radiographic contrast agent barium sulfate qualifies as a device rather than a drug. ...
Previous 10 Next 10